Discover 1,670 paid clinical trials in Princeton, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,670
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for
Myelodysplastic Syndrome
Location: New Brunswick NJ, Livingston NJ, Toms River NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06577441
Phase 2, Recruiting
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
for
Breast Neoplasms, Breast Cancer, Breast Tumors, Angiosarcoma,
Location: New Brunswick NJ, Philadelphia PA, New York NY,
Sponsor: QuantumLeap Healthcare Collaborative
Sex: All
Age: 18+
Code: NCT01042379
Phase 2, Recruiting
Study of APR-1051 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: New Brunswick NJ, Fairfax VA, Cleveland OH, Irving TX,
Sponsor: Aprea Therapeutics
Sex: All
Age: 18+
Code: NCT06260514
Phase 1, Recruiting
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
for
NSCLC, Stage I
Location: New Brunswick NJ, Hershey PA, Richmond VA,
Sponsor: Greg Durm, MD
Sex: All
Age: 18+
Code: NCT04317534
Phase 2, Recruiting
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: New Brunswick NJ, Philadelphia PA, New Haven CT,
Sponsor: Regeneron Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT05125016
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
for
Carcinoma, Non-Small-Cell Lung
Location: New Brunswick NJ, Philadelphia PA, New York NY,
Sponsor: Johnson & Johnson Enterprise Innovation Inc.
Sex: All
Age: 18+
Code: NCT06667908
Phase 2, Recruiting
Naltrexone and Propranolol Combined With Immunotherapy
for
Advanced Melanoma
Location: New Brunswick NJ
Sponsor: Sarah Weiss
Sex: All
Age: 18+
Code: NCT05968690
Phase 1, Recruiting
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
for
Melanoma
Location: New Brunswick NJ, Philadelphia PA, Easton PA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06246916
Phase 3, Recruiting
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
for
Cancer
Location: New Brunswick NJ, Philadelphia PA, New York NY,
Sponsor: MBrace Therapeutics
Sex: All
Age: 18+
Code: NCT06014658
Phase 1, Phase 2, Recruiting
Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer
for
Breast Cancer
Location: New Brunswick NJ
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 18+
Code: NCT05736367
Recruiting
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
for
Melanoma
Location: New Brunswick NJ
Sponsor: Rutgers, The State University of New Jersey
Sex: All
Age: 18+
Code: NCT05373823
Recruiting
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
for
Ovarian Cancer, Fallopian Tube Cancer,
Location: New Brunswick NJ, New York NY, Hackensack NJ,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06824467
Phase 3, Recruiting
Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma
for
Follicular Lymphoma
Location: New Brunswick NJ, Ann Arbor MI, Miami FL
Sponsor: Juan P. Alderuccio, MD
Sex: All
Age: 18+
Code: NCT04998669
Phase 2, Recruiting
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
for
Multiple Myeloma
Location: New Brunswick NJ, Philadelphia PA, New York NY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05201781
Phase 4, Recruiting
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
for
Solid Tumors With HRAS Alterations,
Location: New Brunswick NJ, Boston MA, Pittsburgh PA, Columbus OH,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06026410
Phase 1, Recruiting
The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer
for
Rectal Cancer
Location: New Brunswick NJ, Brooklyn NY, New York NY, Chicago IL
Sponsor: Weill Medical College of Cornell University
Sex: All
Age: 18 - 70+
Code: NCT05943210
Recruiting
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Location: New Brunswick NJ, Morristown NJ, Philadelphia PA,
Sponsor: Sumitomo Pharma America, Inc.
Sex: All
Age: 12+
Code: NCT04988555
Phase 1, Phase 2, Recruiting
Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA)
for
Leiomyosarcoma
Location: New Brunswick NJ, Columbus OH, Jacksonville FL,
Sponsor: Philogen S.p.A.
Sex: All
Age: 16 - 70+
Code: NCT03420014
Phase 2, Recruiting
A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer
for
Non-muscle Invasive Bladder Cancer,
Location: New Brunswick NJ, New York NY, Tampa FL,
Sponsor: John Sfakianos
Sex: All
Age: 18+
Code: NCT06503614
Phase 2, Recruiting
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
for
Metastatic Breast Cancer
Location: New Brunswick NJ, New York NY, Baltimore MD, Boston MA,